Stryker Corp logo

Stryker Corp (SYK)

Market Open
29 Apr, 19:01
NYSE NYSE
$
371. 02
+4.53
+1.24%
$
144.99B Market Cap
43.11 P/E Ratio
3.2% Div Yield
28,198 Volume
10.41 Eps
$ 366.49
Previous Close
Day Range
366.06 371.77
Year Range
314.93 406.19

Summary

SYK trading today higher at $371.02, an increase of 1.24% from yesterday's close, completing a monthly increase of 0.47% or $1.73. Over the past 12 months, SYK stock gained 2.36%.
SYK pays dividends to its shareholders, with the most recent payment made on Jan 31, 2025. The next announced payment will be in In 1 day on Apr 30, 2025 for a total of $0.84.
The last earnings report, released on Yesterday at 12:00 AM, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.88%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 10 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track SYK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

SYK Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
Stryker to participate in the Bank of America Securities 2025 Global Healthcare Conference

Stryker to participate in the Bank of America Securities 2025 Global Healthcare Conference

Portage, Michigan, April 29, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2025 Global Healthcare Conference on Tuesday, May 13, 2025, at the Encore at Wynn Hotel in Las Vegas, Nevada. Representing the company will be Preston Wells, Vice President and Chief Financial Officer, and Jason Beach, Vice President, Finance and Investor Relations.

Globenewswire | 7 hours ago
Gear Up for Stryker (SYK) Q1 Earnings: Wall Street Estimates for Key Metrics

Gear Up for Stryker (SYK) Q1 Earnings: Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Stryker (SYK) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks | 1 day ago
Stryker (SYK) Reports Next Week: Wall Street Expects Earnings Growth

Stryker (SYK) Reports Next Week: Wall Street Expects Earnings Growth

Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 5 days ago

Stryker Corp Dividends

Stryker Corp logo
SYK 4 weeks ago
Announced
Quarterly
$0.84 Per Share
Stryker Corp logo
SYK 3 months ago
Paid
Quarterly
$0.84 Per Share
Stryker Corp logo
SYK 6 months ago
Paid
Quarterly
$0.8 Per Share
Stryker Corp logo
SYK 10 months ago
Paid
Quarterly
$0.8 Per Share
Stryker Corp logo
SYK 27 Mar 2024
Paid
Quarterly
$0.8 Per Share

Stryker Corp Earnings

28 Apr 2025 Date
-
Cons. EPS
-
EPS
28 Jan 2025 Date
3.87
Cons. EPS
4.01
EPS
31 Oct 2024 Date
2.77
Cons. EPS
-
EPS
29 Oct 2024 Date
2.77
Cons. EPS
2.87
EPS
1 Aug 2024 Date
2.79
Cons. EPS
-
EPS
Stryker Corp logo
SYK 4 weeks ago
Announced
Quarterly
$0.84 Per Share
Stryker Corp logo
SYK 3 months ago
Paid
Quarterly
$0.84 Per Share
Stryker Corp logo
SYK 6 months ago
Paid
Quarterly
$0.8 Per Share
Stryker Corp logo
SYK 10 months ago
Paid
Quarterly
$0.8 Per Share
Stryker Corp logo
SYK 27 Mar 2024
Paid
Quarterly
$0.8 Per Share
28 Apr 2025 Date
-
Cons. EPS
-
EPS
28 Jan 2025 Date
3.87
Cons. EPS
4.01
EPS
31 Oct 2024 Date
2.77
Cons. EPS
-
EPS
29 Oct 2024 Date
2.77
Cons. EPS
2.87
EPS
1 Aug 2024 Date
2.79
Cons. EPS
-
EPS

Stryker Corp (SYK) FAQ

What is the stock price today?

The current price is $371.02.

On which exchange is it traded?

Stryker Corp is listed on NYSE.

What is its stock symbol?

The ticker symbol is SYK.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 144.99B.

Has Stryker Corp ever had a stock split?

No, there has never been a stock split.

Stryker Corp Profile

Medical Devices Industry
Healthcare Sector
Mr. Kevin A. Lobo CEO
NYSE Exchange
US8636671013 ISIN
United States Country
52,000 Employees
- Last Dividend
17 May 2004 Last Split
- IPO Date

Overview

Stryker Corporation is a leading medical technology company with a primary focus on providing innovative solutions in the medical field. The company operates through two main segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. These segments cater to a wide array of medical needs, from total joint replacements and trauma surgeries to advanced neurosurgical and neurovascular solutions. Founded in 1941 and based in Portage, Michigan, Stryker has grown into a global entity, distributing its products in approximately 75 countries. The company's commitment to enhancing patient and caregiver outcomes is evident through its extensive product portfolio, advanced medical devices, and a strategic approach to market distribution and customer engagement.

Products and Services

Stryker Corporation offers a diverse range of products and services designed to cater to various facets of medical care, spanning various specialties and requirements. These include:

  • Orthopaedics and Spine: This involves providing implants used in total joint replacements for hip, knee, and shoulder surgeries, along with trauma and extremities surgeries. The segment is also known for its spinal implant products, which consist of systems for cervical and thoracolumbar applications, including fixation, minimally invasive, and interbody systems targeted at spinal injury, complex spine, and degenerative therapies.
  • MedSurg and Neurotechnology: A broad range of surgical equipment and surgical navigation systems fall under this segment, alongside endoscopic and communications systems. Stryker also offers products aimed at enhancing patient handling, emergency medical care, and intensive care through disposable products, reprocessed and remanufactured medical devices. Additionally, clinical communication and workflow solutions, along with a variety of medical device products for different specialties, are provided, focusing on patient and caregiver safety technologies.
  • Neurosurgical, Neurovascular, and Craniomaxillofacial Implant Products: This category includes products for minimally invasive endovascular procedures, brain and open skull-based surgical procedures, and biosurgery products like synthetic bone grafts and vertebral augmentation products. For the treatment of acute ischemic and hemorrhagic stroke, minimally invasive products are offered. The segment also covers craniomaxillofacial implant products, including devices for cranial, maxillofacial, and chest wall surgeries, as well as dural substitutes and sealants.

These products are made available to doctors, hospitals, and other healthcare facilities through a blend of company-owned subsidiaries and branches, supplemented by a network of third-party dealers and distributors worldwide.

Contact Information

Address: 1941 Stryker Way
Phone: 269 385 2600